Shashikant Lele is an Oncology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 313 publications with 16,010 citations (h-index 52); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Gynecologic Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Elm And Carlton Streets
Buffalo, NY 142630001
Telephone
716-845-2300Provider last certified this registry record 20 Jan 2021.
Clinical trials
- Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Sponsor: Roswell Park Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- ABBVIE INC.Program year20243 payments
- Dilon Technologies, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2013–2025 per NIH RePORTER. The latest:
- Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
Roswell Park Cancer Institute Corp
FY2025$305,626UG1CA233191 - Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
Roswell Park Cancer Institute Corp
FY2024$437,615UG1CA233191 - Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
Roswell Park Cancer Institute Corp
FY2023$399,023UG1CA233191
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Science Translational Medicine
2022 - Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Journal for ImmunoTherapy of Cancer
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Philip McCarthy, MD
Roswell Park Comprehensive Cancer Center
Saby George, MD
Roswell Park Comprehensive Cancer Center
Eunice Wang, MD
Roswell Park Comprehensive Cancer Center
Marco Davila, MD
Roswell Park Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”